Single-Use Bioreactor Market

Single-Use Bioreactor Market is valued at USD 3.21 Billion in 2021 and expected to reach USD 11.86 Billion by 2028 with a CAGR of 20.5% over the forecast period.

Single-Use Bioreactor Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028. Demand in Efficient Vaccines is a key driving factor for the growth of the Single-Use Bioreactor Market.

Scope of Single-Use Bioreactor Market Report:

A bioreactor is generally used for growing organisms like animal cell, bacteria, yeast and others in controlled atmosphere and helps in the production of vaccines, antibodies, pharmaceuticals and others. The disposable bioreactor has a disposable bag instead of culture vessel which is known as Single-Use Bioreactor. This disposable bag has three layers of plastic foil made from Polyethylene terephthalate or LPDE, PVA or PVC and contact layer from PVA or PP.  The single use bioreactors are better in performance and scalable compared to stainless steel bioreactors. The traditional bioreactors have a validation issues due to its complexity and cleaning process which is avoided by new single-use bioreactors. This system also holds other advantages like: less turn around time, lowers risk of contamination, cost-effectiveness, and easy to install & movement.

During this COVID-19 pandemic, some industries severely affected, and some industries have flourished. Healthcare industry and Bioprocessing manufacturing industries are affected positively in terms of revenue and funding. Due to the rise in demand of COVID-19 Vaccines and Medications, various governments and organizations are funding and prioritizing Biomanufacturing companies for key technologies like perfusion reactors, single-use equipments, and chromatography resins. Hence, drug and vaccine manufacturers are significantly opting for disposable components like single-use bioreactors to avoid contamination issues.

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2021:	USD 3.21 Billion
Base year considered	2021
Forecast Period CAGR %:	20.5%
Market Size Expected in 2028:	USD 11.86 Billion
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	Sartorius, Xcellerex, Eppendorf, Applikon, Danaher Corporation, Merck Millipore, Thermo Scientific HyClone, PBS Biotech and others
Segments Covered	By Construction, By Mode, By Application, By Size
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

 

Market Segmentation:

Global Single-Use Bioreactor Market report is segmented on the basis of construction, mode, sizes, applications and region & country level. On the basis of construction, it is classified as Stirred Bioreactor and Rocking Bioreactor.  Based upon mode, global Single-Use Bioreactor market is classified into Batch, Continuous, and Fed-Batch. Based upon the size, global Single-Use Bioreactor market is classified into 500L, 1000L, 2000L and 6000L. The market is classified on Application as Academic, Pharmaceutical, Environment and Life sciences.

Single-Use Bioreactor Market Segmentation Analysis:

By Construction

• Stirred Bioreactor
• Rocking Bioreactor

By Mode

• Batch
• Continuous
• Fed-Batch

By Size

• 500L
• 1000L
• 2000L
• 6000L

By Application

• Academic
• Pharmaceutical
• Environment
• Life sciences

Single-Use Bioreactor Market Key Players:

• Sartorius 
• Xcellerex 
• Eppendorf 
• Applikon 
• Danaher Corporation 
• Merck Millipore 
• Thermo Scientific HyClone 
• PBS Biotech 
• Others

News:

Cytiva’s New Manufacturing in Shrewsbury, USA

January 15, 2021; Cytiva opened new manufacturing facility for Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US in December, 2020in collaboration with Biomedical Advanced Research and Development Authority (BARDA). This facility has been developed as a company’s 5 year plan for expanding global manufacturing with total investment $500 million.

Thermo Scientific HyPerforma Bioreactors got Application Specific Enhancements

October 09, 2020; To shift the process specific solutions, Thermo Fisher Scientific introduced the application specific enhancements to HyPerforma Single-Use Bioreactors. It is in creation with the requirements of cell cultures, intensified fed-batch and perfusion. This enables the developers to focus on solutions for diverse bioproduction processes.

Demand for Effective Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market

The major factors driving the growth of global Single-Use Bioreactor market is rising in demand of effective vaccines and medications. They have also been widely accepted for the applications like development of pharmaceutical materials, personalized medicines, upstreaming process, and production of cell cultures. The market has seen significant growth after adaptation of automation and control for Biomanufacturing processes. As per Richard Mirro, Business Manager, Eppendorf there has been exceptional growth in research and development for vaccine along with significant demand in small size and single-use bioreactors has benefited Eppendorf Single-Use Bioreactors portfolio, as they have working volumes up to 50L. Still performance wise technology has not completely proven for single-use bioreactors and application based scalability issues needs to be taken care are some of the restraining factors for Single-Use Bioreactors Market. Product enhancements and developing new features with better performance is expected to create new opportunities in Single-use Bioreactors market.

North America is dominating the Global Single-Use Bioreactor Market

North America is expected to dominate the global Single-Use Bioreactor market over the forecast period attributed to significant Research and Development along with investment in advanced Bioprocessing technologies. Furthermore, meeting the demands of vaccine development, medications and scalability issues has always been the top priority for Biomanufacturing industry. In 2019, ABEC, a biopharmaceutical manufacturer in Pennsylvania, US launched the 6000L of Custom Single Run (CSR) Bioreactors to meet the scalability demands. Europe and Asia-Pacific also expected to substantial growth, as Sartorius, a German based company is leading in R&D processes for vaccine development and helping CanSino Biologics in China to develop vaccine against SARS-CoV-2 by using Sartorius’ Biostat STR single-use Bioreactor system.

On Special Requirement Single-Use Bioreactor Market Report is also available for below region:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Key Benefits for Global Single-Use Bioreactors Market Report:-

• Global Single-Use Bioreactors Market report covers in-depth historical and forecast analysis.
• Global Single-Use Bioreactors Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global Single-Use Bioreactors Market report helps to identify opportunities in marketplace.
• Global Single-Use Bioreactors Market report covers extensive analysis of emerging trends and competitive landscape.